JP2015151366A - Raw material which inhibit visceral fat accumulation in cultured fishes, livestock and pet animals, and feed for animals using the raw material - Google Patents

Raw material which inhibit visceral fat accumulation in cultured fishes, livestock and pet animals, and feed for animals using the raw material Download PDF

Info

Publication number
JP2015151366A
JP2015151366A JP2014026583A JP2014026583A JP2015151366A JP 2015151366 A JP2015151366 A JP 2015151366A JP 2014026583 A JP2014026583 A JP 2014026583A JP 2014026583 A JP2014026583 A JP 2014026583A JP 2015151366 A JP2015151366 A JP 2015151366A
Authority
JP
Japan
Prior art keywords
feed
animal
animals
raw material
creatine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014026583A
Other languages
Japanese (ja)
Other versions
JP6017474B2 (en
Inventor
利男 田中
Toshio Tanaka
利男 田中
康人 島田
Yasuto Shimada
康人 島田
史生 國永
Fumio Kuninaga
史生 國永
康彦 椎名
Yasuhiko Shiina
康彦 椎名
義宣 ▲高▼橋
義宣 ▲高▼橋
Yoshinobu Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mie University NUC
Maruha Nichiro Corp
Original Assignee
Mie University NUC
Maruha Nichiro Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mie University NUC, Maruha Nichiro Corp filed Critical Mie University NUC
Priority to JP2014026583A priority Critical patent/JP6017474B2/en
Publication of JP2015151366A publication Critical patent/JP2015151366A/en
Application granted granted Critical
Publication of JP6017474B2 publication Critical patent/JP6017474B2/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PROBLEM TO BE SOLVED: To provide raw material which can inhibit visceral fat accumulation in cultured fishes, livestock, and pet animals without affecting the animals in their gain in weight and growth.SOLUTION: Visceral fat accumulation in rearing animals are inhibited by feeding raw material containing both anserine and creatine to the rearing animals in combination with feed or by feeding feed containing the raw material to the rearing animals. The combination ratio of anserine to creatine is 5.8 or more and less than 57:1 based on weight.

Description

本発明は、養殖魚類、畜産動物、ペット動物の体重に影響を与えずに内臓脂肪蓄積を抑制する素材、及び該素材を用いた動物用飼料に関する。   The present invention relates to a material that suppresses visceral fat accumulation without affecting the body weight of farmed fish, livestock animals, and pet animals, and an animal feed using the material.

小型魚類や小動物といったペット動物において、高栄養価の飼料が与えられる反面、狭いスペースでの飼育などによる運動不足等により、肥満とそれに伴う病気等が増えている。また、牛、豚、鶏等の家畜、家禽類や、マグロ、ブリ、ハマチ、マダイ、カンパチ等の養殖魚類は、効率的な発育促進のため高タンパク、高脂質、高カロリーな飼料を投与される傾向にある。これらペット動物や畜産動物、養殖魚類に共通して、肥満等に基づく病気や生残率低下といった問題が深刻化しており、その改善が望まれている。特に養殖魚類では、天然魚と比較して必要以上に多く脂肪を蓄えていることによる生残率の低下、体重に対する内臓重量比の増加による可食歩留りの低下、更には、魚種によっては食味の低下といった課題がある。   In pet animals such as small fish and small animals, feed with high nutritional value is given, but on the other hand, obesity and associated diseases are increasing due to lack of exercise due to rearing in a small space. In addition, livestock such as cattle, pigs and chickens, poultry, and farmed fish such as tuna, yellowtail, hamachi, red sea bream, and amberjack are fed a high protein, high fat, high calorie diet to promote efficient growth. It tends to be. In common with these pet animals, livestock animals, and cultured fish, problems such as diseases based on obesity and a decrease in the survival rate are becoming serious, and improvements are desired. Especially in cultured fish, the survival rate decreases due to storing more fat than necessary compared to natural fish, the edible yield decreases due to the increase in the visceral weight ratio relative to the body weight. There is a problem such as lowering.

このような背景技術における課題に対して、特許文献1には、体脂肪の蓄積量減少効果、肥満改善効果等を得るための有効成分としてココナッツの果実胚乳皮を用いた「動物用経口投与組成物及びその製造方法」が開示されている。   In order to solve such problems in the background art, Patent Document 1 discloses an “oral administration composition for animals using coconut fruit endosperm skin as an active ingredient for obtaining an effect of reducing the amount of accumulated body fat, an effect of improving obesity, and the like. Product and its manufacturing method ".

特許文献2には、特定魚類由来のタンパク質のバチルス・サブティリス(Bacillus subtilis)由来のエンドペプチダーゼ酵素による加水分解産物の体重増加の抑制及び/又は体重減少のための使用が開示されている。特許文献2には、高脂肪(HL)であり、かつエネルギーに対するタンパク質の寄与率が80%と高い食事を受けたマウスにおいて加水分解物による内臓脂肪の減少が開示されているものの、この加水分解物は、基本的に体重増加の抑制または減少効果を有する。   Patent Document 2 discloses use of a protein derived from a specific fish for the suppression of weight gain and / or weight loss of a hydrolyzate by an endopeptidase enzyme derived from Bacillus subtilis. Patent Document 2 discloses a reduction in visceral fat due to a hydrolyzate in a mouse having a high fat (HL) and high dietary contribution of protein to energy of 80%. The thing basically has the effect of suppressing or reducing weight gain.

特許文献3には、養殖魚に、魚粉を含有する飼料原料100重量部に対してトウガラシ0.1〜25重量部の割合で添加した飼料を飽食給餌することによって、養殖魚の体重増加率を上げるとともに、体脂肪、特に腹腔内脂肪を減少させる方法が開示されている。   In Patent Document 3, the weight increase rate of the cultured fish is increased by feeding the cultured fish with a feed that is added at a ratio of 0.1 to 25 parts by weight of pepper to 100 parts by weight of the feed raw material containing fish meal. Also disclosed are methods for reducing body fat, particularly intraperitoneal fat.

特許文献4には、養殖魚の体脂肪量と脂質組成を調節することを目的とする、ドコサヘキサエン酸及び/又は共役型ドコサヘキサエン酸を含有する飼料及びそれを用いた養殖方法が開示されている。特許文献4の実施例では、21週間飼育後のニジマス内臓及び筋肉の脂質含量に及ぼす飼料の影響が評価されている。   Patent Document 4 discloses a feed containing docosahexaenoic acid and / or conjugated docosahexaenoic acid, and a culture method using the same, for the purpose of regulating the body fat content and lipid composition of the cultured fish. In the Example of patent document 4, the influence of the feed on the lipid content of rainbow trout viscera and muscle after 21 weeks of breeding is evaluated.

特許文献5には、稚魚期の生残率を向上させ、成長率および肥満度においても十分満足でき、しかも、すじこ油に比べ安価な脂質源を配合したマグロ属魚類用人工配合飼料を提供することを目的とする魚頭部を主原料として採油された魚原油から調製された魚由来リン脂質画分を配合してなるマグロ属魚類稚魚用人工配合飼料が開示されている。   Patent Document 5 provides an artificial mixed feed for tuna fish that improves the survival rate in the juvenile stage, is sufficiently satisfied with the growth rate and obesity level, and contains a lipid source that is less expensive than streak oil. An artificial mixed feed for tuna larvae is disclosed, which is obtained by blending a fish-derived phospholipid fraction prepared from crude oil extracted from the fish head as the main raw material.

特許文献6には、マグロ属魚類を高い成長率、肥満率及び生残率で飼育することを可能にするマグロ属魚類用人工配合飼料およびマグロ属魚類の飼育方法を提供することを目的とする、45〜75重量%の酵素処理魚粉と、3〜10重量%の植物性極性脂質と、を少なくとも含有するマグロ属魚類を飼育するための人工配合飼料が開示されている。   Patent Document 6 aims to provide an artificial mixed feed for tuna fish and a method for rearing tuna fish, which make it possible to breed tuna fish with a high growth rate, obesity rate, and survival rate. An artificially formulated feed for raising tuna fish containing at least 45 to 75% by weight of enzyme-treated fish meal and 3 to 10% by weight of plant polar lipid is disclosed.

特許文献7には、高品位チキンエキスを有効成分とする、抗酸化作用、抗疲労作用及び抗肥満作用を有する機能性食品又は食品素材、ならびに、これらの製造方法が開示されている。   Patent Document 7 discloses a functional food or food material having an antioxidant action, an anti-fatigue action, and an anti-obesity action, and a method for producing them, using a high-grade chicken extract as an active ingredient.

特許文献8には、魚類から抽出され、ヒスチジンを有効成分として含むダイエット加工食品用原料及びそれを用いたダイエット加工食品が開示されている。   Patent Document 8 discloses a diet processed food material extracted from fish and containing histidine as an active ingredient, and a diet processed food using the same.

特許文献9には、クレアチンを有効成分とする体脂肪減少促進剤及び体脂肪減少促進用食品組成物、並びに、体脂肪減少促進方法が開示されている。   Patent Document 9 discloses a body fat reduction promoter containing creatine as an active ingredient, a food composition for promoting body fat reduction, and a method for promoting body fat reduction.

一方、非特許文献1には、ゼブラフィッシュは、魚類のみならず哺乳動物の肥満病態へ外挿性が高く、他の魚類や哺乳動物と生理代謝経路が共通している点について開示されている。   On the other hand, Non-Patent Document 1 discloses that zebrafish is highly extrapolated not only to fish but also to obesity conditions in mammals, and has a common physiological metabolic pathway with other fish and mammals. .

特開2006−81530号公報JP 2006-81530 A 特表2012−530506号公報Special table 2012-530506 gazette 特許第4382795号公報Japanese Patent No. 4382895 特開2002−58435号公報JP 2002-58435 A 特開2013−59293号公報JP 2013-59293 A 特開2008−220180号公報JP 2008-220180 A 特許第4712256号公報Japanese Patent No. 4712256 特開2005−224169号公報JP-A-2005-224169 特開2001−131065号公報JP 2001-131065 A

Takehiko Oka. et al., BMC Physiology. Oct 21;10:21, 2010Takehiko Oka. Et al., BMC Physiology. Oct 21; 10: 21, 2010

従来の抗肥満作用効果を持つ素材やそれを含む飼料は、体重増加を抑制することに重きを置いており、内臓への脂肪蓄積抑制作用についてはほとんど検討されていない。また、内臓脂肪蓄積の抑制を示唆する従来の素材は、同時に体重増または体重減等の体重に対しても影響を伴うものであった。   Conventional materials having an anti-obesity action effect and feeds containing the same place importance on suppressing weight gain, and little investigation has been made on the action of inhibiting fat accumulation in the viscera. In addition, conventional materials that suggest suppression of visceral fat accumulation have an effect on body weight such as weight gain or weight loss at the same time.

こうした背景から、ペット動物の健康維持、また畜産動物や養殖魚類において、体重に対する影響がなく、かつ内臓への脂肪蓄積を抑制する有効な手段が望まれていた。しかしながら、特許文献1〜9には、かかる有効な手段を得るための記載や示唆は見当たらない。   From such a background, there has been a demand for an effective means for maintaining the health of pet animals, and having no influence on body weight in livestock animals and farmed fish and suppressing fat accumulation in internal organs. However, Patent Documents 1 to 9 do not contain any description or suggestion for obtaining such effective means.

本発明の目的は、飼育対象の動物の体重への影響がなく、かつ、内臓脂肪の蓄積抑制効果を有する素材及びこの素材を含む動物用飼料、並びに、この動物用飼料を用いた動物の飼育方法を提供することにある。   An object of the present invention is to provide a material having no effect on the body weight of an animal to be reared and having an effect of suppressing the accumulation of visceral fat, an animal feed containing this material, and animal breeding using this animal feed. It is to provide a method.

本発明者らは、哺乳類への遺伝学的な外挿性が高いことから、養殖魚類のみならず家畜やペット動物等への効果も効率的(省スペース、省コスト、短期間)に検証できるゼブラフィッシュを用いることで、アンセリンとクレアチンがともに含有された飼料の体重及び内臓脂肪蓄積への作用を検討した。その結果、アンセリンとクレアチンがともに含有された飼料をゼブラフィッシュに摂餌させることで、アンセリンとクレアチンの組合せ自体は体重の増減には影響を与えない一方で、肝臓における脂肪蓄積を抑制できることを見出した。内臓において肝臓はその重量比からも脂肪が蓄積される主要臓器と考えられ、肝臓脂肪蓄積抑制効果を内臓脂肪蓄積の抑制効果とした。さらにアンセリンとクレアチンをともに含有する素材を混合した飼料を摂餌させた場合も同様の効果を確認したことから、本発明を完成するに至った。   Since the present inventors have high genetic extrapolation to mammals, the effect on livestock and pet animals as well as farmed fish can be efficiently verified (space-saving, cost-saving, short term). By using zebrafish, the effect of diet containing both anserine and creatine on body weight and visceral fat accumulation was examined. As a result, it was found that by feeding zebrafish with a feed containing both anserine and creatine, the combination of anserine and creatine itself does not affect the increase or decrease in body weight, but can suppress fat accumulation in the liver. It was. In the viscera, the liver is considered to be a major organ in which fat is accumulated from the weight ratio, and the liver fat accumulation inhibitory effect was defined as the visceral fat accumulation inhibitory effect. Furthermore, when the feed which mixed the raw material which contains both anserine and creatine was fed, the same effect was confirmed, and it came to complete this invention.

本発明にかかる飼育動物の内臓脂肪蓄積を抑制するための素材は、アンセリンとクレアチンをともに有効成分として含有することを特徴とする。
また、本発明にかかる飼育動物用の飼料は、上記の素材を含むことを特徴とする。
本発明にかかる飼育方法の一態様は、上記の飼料を飼育動物に給餌、摂取させることを特徴する。
本発明にかかる飼育方法の他の態様は、飼育動物用の飼料と、上記素材とを併用して飼育動物に与え、摂取させることを特徴とする。
本発明にかかる飼育動物の飼育用セットは、飼育動物用の飼料と、該飼料と別に用意された上記の素材とを有することを特徴とする。
A material for suppressing visceral fat accumulation in domestic animals according to the present invention is characterized by containing both anserine and creatine as active ingredients.
Moreover, the feed for domestic animals according to the present invention includes the above-described material.
One aspect of the breeding method according to the present invention is characterized by feeding and ingesting the above-mentioned feed to a breeding animal.
Another aspect of the breeding method according to the present invention is characterized in that a breeding animal feed and the above-mentioned material are used in combination and fed to the breeding animal.
A breeding set for breeding animals according to the present invention is characterized by having a feed for breeding animals and the material prepared separately from the feed.

本発明によれば、養殖魚類、畜産物およびペット動物等の飼育動物に対して、体重の増減や発育等に影響を与えずに、内臓脂肪の蓄積を抑制できる素材を提供することができる。本発明によって、以下の効果が提供可能である。   ADVANTAGE OF THE INVENTION According to this invention, the raw material which can suppress accumulation | storage of a visceral fat can be provided, without affecting increase / decrease in a body weight, growth, etc. with respect to domestic animals, such as cultured fish, livestock products, and a pet animal. The following effects can be provided by the present invention.

(1)養殖魚類や畜産動物、およびペット動物等の内臓脂肪蓄積の抑制。
(2)養殖魚類や畜産動物の内臓疾患の予防、低減による生残率の向上。
(3)ペット動物等の内臓疾患の予防、低減による健康維持。
(4)畜産や魚類養殖における、可食歩留りを維持向上した効率的な生産ならびに高品質な食肉の提供。
(1) Suppression of visceral fat accumulation in farmed fish, livestock animals, and pet animals.
(2) Improvement of survival rate by preventing and reducing visceral diseases in farmed fish and livestock animals.
(3) Maintaining health by preventing and reducing visceral diseases such as pet animals.
(4) Efficient production that maintains and improves edible yield in livestock and fish farming, and provision of high-quality meat.

実施例1における試験期間中のゼブラフィッシュの体重推移を示す。平均値±標準偏差で表記、*は肥満コントロール群とp<0.05(Dunnett-test)、**はp<0.01(Dunnett-test)で有意差があることを示す。The weight change of the zebrafish during the test period in Example 1 is shown. Expressed as mean ± standard deviation, * indicates a significant difference between obesity control group and p <0.05 (Dunnett-test), and ** indicates p <0.01 (Dunnett-test). 実施例1の肝臓組織の顕微鏡画像において脂肪蓄積の見られた部位の面積割合を示す。平均値±標準偏差で表記、**は肥満コントロール群と有意差(p<0.01, Dunnett-test)があることを示す。The area ratio of the site | part in which fat accumulation was seen in the microscope image of the liver tissue of Example 1 is shown. Expressed as mean ± standard deviation, ** indicates that there is a significant difference (p <0.01, Dunnett-test) from the obesity control group. 実施例2における試験期間中のゼブラフィッシュの体重推移を示す。平均値±標準偏差で表記、**は肥満コントロール群と有意差(p<0.01, Dunnett-test)があることを示す。The weight change of the zebrafish during the test period in Example 2 is shown. Expressed as mean ± standard deviation, ** indicates that there is a significant difference (p <0.01, Dunnett-test) from the obesity control group. 実施例2の肝臓組織の顕微鏡画像において脂肪蓄積の見られた部位の面積割合を示す。平均値±標準偏差で表記、**は肥満コントロール群と有意差(p<0.01, Dunnett-test)があることを示す。The area ratio of the site | part in which fat accumulation was seen in the microscope image of the liver tissue of Example 2 is shown. Expressed as mean ± standard deviation, ** indicates that there is a significant difference (p <0.01, Dunnett-test) from the obesity control group. 実施例3における試験期間中のゼブラフィッシュの体重推移を示す。平均値±標準偏差で表記、*は肥満コントロール群と有意差(p<0.05, Dunnett-test)があることを示す。The weight transition of the zebrafish during the test period in Example 3 is shown. Expressed as mean ± standard deviation, * indicates that there is a significant difference (p <0.05, Dunnett-test) from the obesity control group. 実施例3の肝臓組織の顕微鏡画像において脂肪蓄積の見られた部位の面積割合を示す。平均値±標準偏差で表記、**は肥満コントロール群と有意差(p<0.01, Dunnett-test)があることを示す。The area ratio of the site | part in which fat accumulation was seen in the microscope image of the liver tissue of Example 3 is shown. Expressed as mean ± standard deviation, ** indicates that there is a significant difference (p <0.01, Dunnett-test) from the obesity control group.

本発明にかかる動物飼育飼料用の素材は、飼育動物の内臓脂肪蓄積を抑制する作用を得るための有効成分として、クレアチン及びアンセリンを含む。クレアチンとアンセリンを組み合わせることによって、飼育動物の体重に影響を与えることなく、内臓脂肪蓄積を抑制することができる。従って、飼育用の飼料に加えて、クレアチン及びアンセリンを併用することによって、飼料による飼育効果を損なうことなく、飼育動物の内臓脂肪の蓄積を抑制することができる。例えば、飼料が飼育動物の体重増加を目的とする、あるいは体重増加を許容する場合に、素材によって体重増が抑制されることがない。また、飼料が飼育動物の許容される幅での体重維持を目的とする場合には、素材による体重の増減がなく、かかる飼料による体重維持効果に影響を与えることがない。   The material for animal rearing feed according to the present invention contains creatine and anserine as active ingredients for obtaining the action of suppressing visceral fat accumulation in the rearing animals. By combining creatine and anserine, visceral fat accumulation can be suppressed without affecting the weight of the domestic animal. Therefore, by using creatine and anserine in combination with feed for breeding, accumulation of visceral fat in the breeding animals can be suppressed without impairing the breeding effect of the feed. For example, when the feed is intended to increase the weight of the domestic animal or allows the weight increase, the weight increase is not suppressed by the material. Further, when the feed is intended to maintain the weight within the allowable range of the domestic animal, there is no increase or decrease in the body weight due to the material, and the weight maintenance effect by the feed is not affected.

従って、飼料が、飼育動物の生育に必要なカロリー源や栄養素を含み、生育に伴う体重増を目的とする場合においては、クレアチン及びアンセリンを含む素材を併用することによって、この飼料を飼育動物に与えることによる目的とする体重増を抑制せずに、内臓脂肪の蓄積を抑制することができる。タンパク質、脂質及びカロリーの少なくとも1種の含有量が高い生育効率が良い飼料を飼育動物に与え、通常であれば内臓脂肪が蓄積しやすい場合においても、クレアチン及びアンセリンを含む素材を併用することによって、高い生育効率を維持しつつ、内臓脂肪の蓄積を抑制することができる。   Therefore, when the feed contains caloric sources and nutrients necessary for the growth of the domestic animals and the purpose is to increase the body weight associated with the growth, the feed can be given to the domestic animals by using a material containing creatine and anserine. Accumulation of visceral fat can be suppressed without suppressing the intended increase in weight due to giving. By feeding a breeding animal with a high growth efficiency feed that has a high content of at least one of protein, lipid and calorie, and even when visceral fat tends to accumulate normally, by using a material containing creatine and anserine together The accumulation of visceral fat can be suppressed while maintaining high growth efficiency.

成体動物の生体の維持のための飼料を飼育動物に給餌する場合にも、クレアチン及びアンセリンを含む素材を併用することによって、飼料を給餌することによる目的とする飼育動物の体重の維持あるいは体重増または体重減を損なうことなく、目的とする内臓脂肪蓄積抑制効果を得ることができる。   Maintaining the weight or weight gain of the intended breeding animal by feeding the feed, in combination with a material containing creatine and anserine, even when feeding the breeding animal for the maintenance of adult living organisms Or the target visceral fat accumulation inhibitory effect can be acquired, without impairing weight loss.

このように、飼育動物に、アンセリンとクレアチンをともに含有することを特徴とする素材と飼料を併用して摂食させ、あるいはその素材を含有する飼料を摂食させることによって、本発明の効果が得られる。従って、本発明にかかる素材は、飼育用の飼料を用いた動物飼育における内臓脂肪蓄積防止用の補助剤として利用することができる。   Thus, the effect of the present invention can be obtained by feeding a domestic animal with a material and feed that are characterized by containing both anserine and creatine, or by feeding a feed containing the material. can get. Therefore, the material according to the present invention can be used as an auxiliary agent for preventing visceral fat accumulation in animal breeding using feed for breeding.

本発明にかかる動物の飼育には、動物の育成、成体動物の維持等が含まれる。   Animal breeding according to the present invention includes animal breeding, adult animal maintenance, and the like.

飼育動物としては以下の種々の動物を挙げることができる。   Examples of domestic animals include the following various animals.

養殖魚類としては、例えばマグロ、ブリ、ハマチ、マダイ、カンパチ、ギンザケ、アジ、ヒラメ、フグ、クルマエビ、ニジマス、アユ、コイ、フナ、ウナギ、ティラピア、ハクレン、ソウギョなどが挙げられる。   Examples of the cultured fish include tuna, yellowtail, hamachi, red sea bream, amberjack, coho salmon, horse mackerel, flounder, puffer fish, tiger prawn, rainbow trout, sweetfish, carp, crucian carp, eel, tilapia, haklen, and carp.

畜産動物としては、例えば乳牛や肉牛、豚、羊、馬、ウサギ、ニワトリ、ウズラ、アヒル、七面鳥、ダチョウなどが挙げられる。   Examples of livestock animals include dairy cows, beef cattle, pigs, sheep, horses, rabbits, chickens, quails, ducks, turkeys and ostriches.

ペット動物では、例えばイヌ、ネコ、モルモット、ハムスター、ラット、マウス、フェレット、リクガメ、ヘビ、カメレオン、トカゲ、コキンチョウ、メジロ、フクロウ、インコ、ヨウム、マーモセット、リスザル、グッピー、プラティ、メダカ、ネオンテトラ、ゼブラフィッシュ、ディスカス、エンゼルフィッシュ、ドジョウ、シクリッド、ベタ、コリドラス、オトシン、ロリカリア、ナマズ、レインボーフィッシュ、ハゼ、ハコフグ、ザリガニ、ビーシュリンプ、ヌマエビ、テナガエビなどが挙げられる。   In pet animals, for example, dogs, cats, guinea pigs, hamsters, rats, mice, ferrets, tortoises, snakes, chameleons, lizards, small butterflies, white-eye, owls, parakeets, yew, marmoset, squirrel monkeys, guppy, platy, medaka, neon tetra, Examples include zebrafish, discus, angelfish, loach, cichlid, betta, Corydoras, otocin, lorikaria, catfish, rainbowfish, goby, boxfish, crayfish, bee shrimp, tiger shrimp, and gibbon.

本発明にかかる飼料用の素材は、内臓脂肪の蓄積を抑制するための有効成分として、クレアチン及びアンセリンを含む。アンセリンとクレアチンをともに含有する素材としては、魚類、両生類、爬虫類、鳥類、または哺乳類の肉、骨または皮から得られた動物性由来のエキス素材が挙げられる。素材の形態は、生の状態でも良いし、乾燥物、抽出物及び濃縮物などの加工品を用いても良い。更に、アンセリン及びクレアチンの少なくとも一方の一部または全部が精製品であってもよい。   The feed material according to the present invention contains creatine and anserine as active ingredients for suppressing the accumulation of visceral fat. Examples of the material containing both anserine and creatine include fish, amphibians, reptiles, birds, or animal-derived extract materials obtained from mammalian meat, bone or skin. The raw material may be in a raw state, or a processed product such as a dried product, an extract and a concentrate may be used. Furthermore, a part or all of at least one of anserine and creatine may be a purified product.

更に、エキス素材及び濃縮物素材としては、以下のものを挙げることができる。
A:魚類、両生類、爬虫類、鳥類、または哺乳類の肉、骨または皮、もしくはその処理廃液から得られた動物性由来のエキス。
B:上記Aの肉、骨及び皮をミンチ状として抽出剤を加え、攪拌して得られる抽出液及びその濃縮物。
Furthermore, the following can be mentioned as an extract raw material and a concentrate raw material.
A: An animal-derived extract obtained from fish, amphibians, reptiles, birds, or mammalian meat, bone or skin, or a waste solution thereof.
B: An extract obtained by adding the extractant in the form of minced meat, bone and skin of A and stirring, and a concentrate thereof.

これらエキス及び濃縮物は、脱塩、濃縮操作、精製操作等によりさらに高濃縮、あるいは精製してもよい。また、必要に応じて乾燥して乾燥物や粉末として提供してもよい。   These extracts and concentrates may be further concentrated or purified by desalting, concentration operation, purification operation, or the like. Moreover, you may dry as needed and may provide as a dried material or powder.

上記Aの方法における廃液として、魚肉を蒸煮した際に得られる煮汁、魚を水洗した際に得られる洗浄水及び魚肉のドリップなどを挙げることができる。これら廃液を、雑菌などの混入や繁殖がない条件において、加熱処理、濾過処理、減圧濃縮、凍結乾燥処理などにより濃縮及び/または乾燥を行って動物由来エキスを得ることができる。これら廃液を用いる場合、素材摂食時の嗜好性を考慮して、必要に応じて濾過などの分離処理や各種精製方法によって固形分や不要成分の除去を行ってもよい。   Examples of the waste liquid in the method A include boiling water obtained when steaming fish meat, washing water obtained when water washing fish, and drip of fish meat. These waste liquids can be concentrated and / or dried by heat treatment, filtration treatment, vacuum concentration, lyophilization treatment, etc. under conditions where there is no contamination or propagation of germs or the like, and animal-derived extracts can be obtained. When these waste liquids are used, solid content and unnecessary components may be removed by separation processing such as filtration and various purification methods as necessary in consideration of the preference at the time of feeding the material.

上記Bの方法における動物由来エキスを得る場合の抽出温度は、0〜100℃が望ましい。抽出溶媒は水に限らず、水に酸、アルカリ、無機塩などを添加したもの、含水エタノールなどの適当な有機溶媒を水に組み合わせたものが利用できる。抽出の際に得られる残渣物は、抽出液と分離し、好ましくは抽出液について脱塩処理を行う。得られた濃縮液を濃縮乾固することで当該エキスを得ることができる。   The extraction temperature for obtaining the animal-derived extract in the method B is preferably 0 to 100 ° C. The extraction solvent is not limited to water, and water in which an acid, an alkali, an inorganic salt, or the like is added, or a combination of an appropriate organic solvent such as hydrous ethanol in water can be used. The residue obtained at the time of extraction is separated from the extract, and the extract is preferably desalted. The extract can be obtained by concentrating and drying the obtained concentrated solution.

抽出剤としては、素材摂食時の嗜好性を損なわない範囲で、塩酸、酢酸、硫酸、硝酸、乳酸、クエン酸、グルコン酸及びL−アスコルビン酸などの酸性水溶液、水酸化ナトリウム、水酸化カルシウム及び水酸化カリウムなどの塩基性水溶液、塩化ナトリウム、塩化カリウム、塩化マグネシウム及び塩化カルシウムなどの塩水溶液、エタノール、アセトン及びヘキサンなどの有機溶剤を用いることができる。   As an extractant, acidic aqueous solutions such as hydrochloric acid, acetic acid, sulfuric acid, nitric acid, lactic acid, citric acid, gluconic acid and L-ascorbic acid, sodium hydroxide, calcium hydroxide are used within the range that does not impair the palatability at the time of feeding. And basic aqueous solutions such as potassium hydroxide, salt aqueous solutions such as sodium chloride, potassium chloride, magnesium chloride and calcium chloride, and organic solvents such as ethanol, acetone and hexane.

素材中に含まれるアンセリンとクレアチンの配合割合は、重量%においてクレアチンを1としたときアンセリンが5.8以上、より好ましくはアンセリンが5.8以上57未満である。   The blending ratio of anserine and creatine contained in the material is such that the anserine is 5.8 or more, more preferably 5.8 or more and less than 57 when creatine is 1 in weight%.

本発明にかかる素材は、賦形剤や希釈剤等を用いて、錠剤、粉剤、顆粒剤、液剤、乳化剤などの製剤とすることができる。この製剤は、アンセリンおよびクレアチンと賦形剤とを含み、更に必要に応じて、油脂、香料、乳化剤などを配合して構成されるものであってもよい。例えば、賦形剤にはデキストリン、油脂には牛脂、香料には魚臭フレーバー、乳化剤にはグリセリン脂肪酸エステルが用いうるが、特に限定されるものではない。更に、水や、飼料用成分として許容される塩の水溶液等の液媒体中にアンセリンおよびクレアチンを含有させた液剤としてもよい。製剤中のアンセリンとクレアチンの配合割合は、アンセリンが3.0重量%〜50.0重量%、より好ましくは3.6重量%〜11.2重量%であり、クレアチンが0.05重量%〜5.0重量%、より好ましくは0.06重量%〜1.5重量%である。   The material according to the present invention can be made into preparations such as tablets, powders, granules, liquids, and emulsifiers using excipients and diluents. This preparation may contain anserine and creatine and an excipient, and may further comprise fats, fragrances, emulsifiers and the like as necessary. For example, dextrin can be used as the excipient, beef fat as the fat and oil, fish odor flavor as the fragrance, and glycerin fatty acid ester as the emulsifier, but it is not particularly limited. Furthermore, it is good also as a liquid agent which contained anserine and creatine in liquid media, such as water and the aqueous solution of the salt accept | permitted as a feed ingredient. The blending ratio of anserine and creatine in the preparation is 3.0% to 50.0% by weight of anserine, more preferably 3.6% to 11.2% by weight, and 0.05% by weight to creatine. It is 5.0% by weight, more preferably 0.06% by weight to 1.5% by weight.

本発明にかかる素材を飼育動物用の飼料に配合することによって、内臓脂肪蓄積防止効果を有する飼料を得ることができる。あるいは、飼育動物用の飼料にアンセリン及びクレアチンを配合することによって内臓脂肪蓄積防止効果を有する飼料を得ることができる。アンセリン及びクレアチンを配合するための動物用飼料については、特に限定されず、飼育動物の飼育目的に応じて選択することができる。例えば、通常用いられている市販の、あるいは目的に応じて調製された養殖魚飼育用飼料、畜産動物用飼料、ペット動物用飼料などを用いることができる。内臓脂肪蓄積防止効果を有する飼料中のアンセリン及びクレアチンの含有割合は、アンセリンが3.0重量%〜50.0重量%、より好ましくは3.6重量%〜11.2重量%であり、クレアチンが0.05重量%〜5.0重量%、より好ましくは0.06重量%〜1.5重量%の範囲にある。   By blending the material according to the present invention into feed for domestic animals, a feed having an effect of preventing visceral fat accumulation can be obtained. Or the feed which has the visceral fat accumulation | storage prevention effect can be obtained by mix | blending anserine and creatine with the feed for domestic animals. It does not specifically limit about the animal feed for mix | blending anserine and creatine, It can select according to the breeding purpose of a domestic animal. For example, commercially available feeds for raising cultured fish, feeds for livestock animals, feeds for pet animals, etc. that are usually used or prepared according to the purpose can be used. The content ratio of anserine and creatine in the feed having the visceral fat accumulation preventing effect is 3.0% to 50.0% by weight of anserine, more preferably 3.6% to 11.2% by weight. Is in the range of 0.05 wt% to 5.0 wt%, more preferably 0.06 wt% to 1.5 wt%.

本発明にかかる素材を飼育動物に給餌して摂食させる方法としては、
A:通常飼料とは別に本発明にかかる素材を用意し、これらを同時に、及び/または時間差を設けて与える方法、
B:通常飼料に本発明にかかる素材を混合した混合飼料として与える方法、並びに
C:これらの方法A及びBを併用する方法、
を挙げることができる。
As a method of feeding and feeding a domestic animal with the material according to the present invention,
A: A method for preparing materials according to the present invention separately from normal feed and giving them simultaneously and / or with a time difference,
B: A method of giving a mixed feed in which the material according to the present invention is mixed with a normal feed, and C: a method of using these methods A and B together,
Can be mentioned.

また、飼育動物用の飼料と、本発明にかかる素材と、あるいはこの素材を含む飼料と、を併用して給餌する方法を用いることもでき、更には、飼育動物用の飼料と、本発明にかかる素材と、あるいはこの素材を含む飼料と、を混合したものを給餌する方法を用いることもできる。   In addition, it is possible to use a method of feeding in combination with feed for domestic animals and the material according to the present invention, or feed containing this material, and further, feed for domestic animals and the present invention. A method of feeding a mixture of such a material and a feed containing this material can also be used.

なお、通常飼料とは、飼育動物の飼育目的のために日常的に給餌する飼育用飼料であり、生飼料及び配合飼料等の少なくとも1種が通常飼料として用いられる。通常飼料は、飼育動物の種類、飼育目的に応じて選択して使用する。   The normal feed is a breeding feed that is routinely fed for the purpose of breeding domestic animals, and at least one of a raw feed and a mixed feed is used as the normal feed. Usually, feed is selected and used according to the kind of breeding animal and breeding purpose.

通常飼料としての配合飼料等に本発明にかかる素材を混合して用いる場合は、本発明にかかる素材を、乾燥粉末や濃縮エキスの形態で用いることが望ましい。乾燥粉末素材は例えば、CBEX(日本ハム株式会社)、マリンアクティブ10(焼津水産化学工業株式会社)を用いることができる。投与期間は4週間以上、好ましくは5週間以上が望ましい。   When the raw material according to the present invention is used by mixing it with a mixed feed as a normal feed, it is desirable to use the raw material according to the present invention in the form of a dry powder or a concentrated extract. As the dry powder material, for example, CBEX (Nippon Ham Co., Ltd.), Marine Active 10 (Yaizu Fisheries Chemical Co., Ltd.) can be used. The administration period is 4 weeks or more, preferably 5 weeks or more.

飼育動物への素材の投与量、すなわち飼育動物での摂食量は、飼育動物の種類、飼育目的等により異なり、適宜選択される。例えば、一般的な魚類に投与する場合は、通常、一日につき体重1kgあたりアンセリンが100mg〜5000mg、クレアチンが5.0mg〜500mg、より好ましくはアンセリンが440mg〜1343mg、クレアチンが7.7mg〜169mgの投与量が適している。これらの投与量を通常一日1回または複数回に分けて投与する。その投与量は一日の中で適宜選択することができる。   The dose of the material to the domestic animal, that is, the amount of food intake in the domestic animal varies depending on the kind of the domestic animal, the purpose of breeding, etc., and is appropriately selected. For example, when administered to a general fish, anserine is usually 100 mg to 5000 mg, creatine is 5.0 mg to 500 mg, more preferably 440 mg to 1343 mg, and creatine is 7.7 mg to 169 mg per kg body weight per day. Is suitable. These doses are usually administered once or divided into several times a day. The dose can be appropriately selected during the day.

更に、内臓脂肪蓄積防止効果を有する飼料中のアンセリン及びクレアチンの配合量は、アンセリンが3.6重量%〜11.2重量%、クレアチンが0.06重量%〜1.5重量%の範囲にあることが好ましい。   Furthermore, the blending amount of anserine and creatine in the feed having the visceral fat accumulation preventing effect is in the range of 3.6% to 11.2% by weight of anserine and 0.06% to 1.5% by weight of creatine. Preferably there is.

また、飼育用の飼料と、内臓脂肪蓄積防止効果を有する素材とを併用して飼育を行うとき、例えば一般的な魚類に投与する場合、飼料と素材との合計量に対して、一日につき体重1kgあたりアンセリンが100mg〜5000mg、クレアチンが5.0mg〜500mg、より好ましくはアンセリンが440mg〜1343mg、クレアチンが7.7mg〜169mgの投与量が適している。これらの投与量を通常一日1回または複数回に分けて投与する。その投与量は一日の中で適宜選択することができる。先に、挙げたCの方法により飼育を行う場合にも、飼料と素材との合計量に対して、例えば一般的な魚類に投与する場合、飼料と素材との合計量に対して、一日につき体重1kgあたりアンセリンが100mg〜5000mg、クレアチンが5.0mg〜500mg、より好ましくはアンセリンが440mg〜1343mg、クレアチンが7.7mg〜169mgの投与量が適している。これらの投与量を通常一日1回または複数回に分けて投与する。その投与量は一日の中で適宜選択することができる。   In addition, when rearing together with feed for breeding and a material having an effect of preventing visceral fat accumulation, for example, when administered to general fish, the total amount of feed and material per day A dose of 100 mg to 5000 mg anserine, 5.0 mg to 500 mg creatine, more preferably 440 mg to 1343 mg anserine, and 7.7 mg to 169 mg creatine per kg body weight is suitable. These doses are usually administered once or divided into several times a day. The dose can be appropriately selected during the day. In the case of breeding by the above-mentioned method C, the total amount of feed and material, for example, when administered to general fish, the total amount of feed and material is one day. A dose of 100 mg to 5000 mg of anserine, 5.0 mg to 500 mg of creatine, more preferably 440 mg to 1343 mg of anserine and 7.7 mg to 169 mg of creatine per kg body weight is suitable. These doses are usually administered once or divided into several times a day. The dose can be appropriately selected during the day.

以下に本発明を実施例により詳細に説明するが、本発明はこれら実施例により限定されるものではない。   EXAMPLES The present invention will be described in detail below with reference to examples, but the present invention is not limited to these examples.

(実施例1)
ゼブラフィッシュの成魚飼育はTHE ZEBRAFISH BOOK(by Monte Westerfield, Institute of Neuroscience, University of Oregon)に従った。AB line 株のゼブラフィッシュのメス成魚を用いて、飼育用の飼料としてアルテミアを投与した。アルテミア卵(ミヤコ化学株式会社)を3.0%塩化ナトリウム水溶液中で24時間培養し、孵化したアルテミアを含む培養液を1/10量に濃縮したものを用いた。試験期間中このアルテミア培養濃縮液を、非肥満誘導群には0.5 mL/匹/日、肥満誘導群には6.0mL/匹/日で与えた。被験物質としてアンセリン硝酸塩(シグマ社)及びクレアチン(シグマ社)をそれぞれ単独で配合した飼料を調製し、用いた。これら被験物質を配合した素材含有飼料中のアンセリンとクレアチンの重量%を表1に示す。これら素材含有飼料を、アンセリンについては4.0 mg/g体重/日、クレアチンについては0.42 mg/g体重/日の摂取量となるように、アルテミア飼料とは別に投与した。
Example 1
Zebrafish adult breeding was according to THE ZEBRAFISH BOOK (by Monte Westerfield, Institute of Neuroscience, University of Oregon). Artemia was administered as a feed for rearing by using female zebrafish females of the AB line strain. Artemia eggs (Miyako Chemical Co., Ltd.) were cultured in a 3.0% aqueous sodium chloride solution for 24 hours, and a culture solution containing hatched artemia was concentrated to 1/10 amount. During the test period, this Artemia culture concentrate was given to the non-obesity induction group at 0.5 mL / animal / day and to the obesity induction group at 6.0 mL / animal / day. The feed which mix | blended each of the anserine nitrate (Sigma) and the creatine (Sigma) individually as a test substance was prepared and used. Table 1 shows the weight percentages of anserine and creatine in the feed containing raw materials containing these test substances. These material-containing feeds were administered separately from the artemia feed so that the intake amount was 4.0 mg / g body weight / day for anserine and 0.42 mg / g body weight / day for creatine.

コントロール群には被験物質の代わりにグルテンを配合した飼料を投与、摂取させた。肥満誘導群は、6週間の試験期間のうち最初の2週間は肥満誘導のみ行い、その後4週間の被験物質投与を行った。週に1回各個体の体重測定を行い、エンドポイント(6週目)に氷中で安楽死させたのち、肝臓を摘出した。摘出肝臓の凍結組織切片を常法により作製しオイルレッドO染色法により肝臓組織脂肪染色を行い、光学顕微鏡で画像を取得した。画像解析ソフトWinROOF(三谷商事株式会社)を用いて視野内の全細胞面積のうち染色部位面積の割合を定量した。   In the control group, a feed containing gluten instead of the test substance was administered and ingested. In the obesity induction group, only the obesity induction was performed for the first 2 weeks in the 6-week test period, and then the test substance administration was performed for 4 weeks. Each individual was weighed once a week, euthanized on ice at the end point (6th week), and then the liver was removed. A frozen tissue section of the excised liver was prepared by a conventional method, liver tissue fat was stained by an oil red O staining method, and an image was obtained with an optical microscope. Using the image analysis software WinROOF (Mitani Corporation), the proportion of the stained area out of the total cell area in the visual field was quantified.

結果を図1および図2に示す。肥満(誘導)コントロール群に対して、アンセリン投与群では体重および肝臓脂肪蓄積量に有意な差は見られず、クレアチン投与群において体重および肝臓脂肪蓄積が有意に低下した。   The results are shown in FIG. 1 and FIG. There was no significant difference in body weight and liver fat accumulation in the anserine administration group compared to the obesity (induction) control group, and body weight and liver fat accumulation were significantly reduced in the creatine administration group.

(実施例2)
ゼブラフィッシュの成魚飼育はTHE ZEBRAFISH BOOK(by Monte Westerfield, Institute of Neuroscience, University of Oregon)に従った。AB line 株のゼブラフィッシュのメス成魚を用いて、飼育用の飼料として配合飼料を投与した。非肥満誘導群は1日あたり体重の3%重量程度の制限給餌を1日1回行い、肥満誘導群は食べなくなるまでの飽食給餌を1日3回行った。被験物質としてアンセリン硝酸塩(シグマ社)及びクレアチン(シグマ社)を混合した素材含有飼料を調製した。これら被験物質を配合した素材含有飼料中のアンセリンとクレアチンの重量%を表2に示す。この素材含有飼料を上記配合飼料とは別に、アンセリンは1.34 mg/g体重/日、クレアチンは0.14mg/g体重/日の摂取量となるように投与した。
(Example 2)
Zebrafish adult breeding was according to THE ZEBRAFISH BOOK (by Monte Westerfield, Institute of Neuroscience, University of Oregon). AB line strain zebrafish female adults were used to administer the mixed feed as feed for breeding. In the non-obesity induction group, restricted feeding of about 3% of the body weight per day was performed once a day, and in the obesity induction group, satiety feeding until eating was stopped three times a day. A material-containing feed in which anserine nitrate (Sigma) and creatine (Sigma) were mixed as test substances was prepared. Table 2 shows the weight percentages of anserine and creatine in the feed containing raw materials containing these test substances. Apart from the above-mentioned mixed feed, this raw material-containing feed was administered such that anserine had an intake of 1.34 mg / g body weight / day and creatine had an intake of 0.14 mg / g body weight / day.

コントロール群には被験物質の代わりにカゼインを配合した飼料を投与、摂取させた。肥満誘導群は、5週間の試験期間のうち最初から被験物質投与を行った。週に1回各個体の体重測定を行い、エンドポイント(5週目)に氷中で安楽死させたのち、肝臓を摘出した。摘出肝臓の凍結組織切片を実施例1と同様にして作製しオイルレッドO染色法により肝臓組織脂肪染色を行い、光学顕微鏡で画像を取得した。画像解析ソフトWinROOF(三谷商事株式会社)を用いて視野内の全細胞面積のうち染色部位面積の割合を定量した。   The control group was administered and ingested a feed containing casein instead of the test substance. In the obesity induction group, the test substance was administered from the beginning of the 5-week test period. Each individual was weighed once a week, euthanized on ice at the end point (5th week), and then the liver was removed. A frozen tissue section of the extracted liver was prepared in the same manner as in Example 1, and liver tissue fat was stained by an oil red O staining method, and an image was obtained with an optical microscope. Using the image analysis software WinROOF (Mitani Corporation), the proportion of the stained area out of the total cell area in the visual field was quantified.

結果を図3および図4に示す。肥満(誘導)コントロール群に対して、アンセリンとクレアチンの投与群では体重増加に有意な差は見られなかった一方で、肝臓脂肪蓄積が有意に低下した。   The results are shown in FIG. 3 and FIG. While there was no significant difference in body weight gain between the anserine and creatine groups compared to the obese (induction) control group, liver fat accumulation was significantly reduced.

(実施例3)
ゼブラフィッシュの成魚飼育はTHE ZEBRAFISH BOOK(by Monte Westerfield, Institute of Neuroscience, University of Oregon)に従った。AB line 株のゼブラフィッシュのメス成魚を用いて、飼料は配合飼料を投与した。非肥満誘導群は1日あたり体重の3%重量程度の制限給餌を1日1回行い、肥満誘導群は食べなくなるまでの飽食給餌を1日3回行った。被験物質としてのサケエキス、カツオエキス、およびチキンエキスを各3.9 mg/g体重/日の投与量となるように混合して内臓脂肪蓄積抑制剤としての素材を調製し素材含有飼料とした。この素材含有飼料中にサケエキス、カツオエキス、およびチキンエキスは各32.5重量%含有され、上記配合飼料とは別に投与した。これらの被験物質に含まれるクレアチンとアンセリンの含有割合(重量%)及びこれらの重量比を表3に示す。これら被験物質を配合した素材含有飼料中のアンセリンとクレアチンの重量%を表4に示す。また、試験期間中の一日あたりのアンセリンとクレアチンそれぞれの、体重1 kgあたり平均摂取量を表5に示す。
(Example 3)
Zebrafish adult breeding was according to THE ZEBRAFISH BOOK (by Monte Westerfield, Institute of Neuroscience, University of Oregon). AB line strain zebrafish female adults were used as the feed. In the non-obesity induction group, restricted feeding of about 3% of the body weight per day was performed once a day, and in the obesity induction group, satiety feeding until eating was stopped three times a day. Salmon extract, bonito extract, and chicken extract as test substances were mixed at a dose of 3.9 mg / g body weight / day to prepare a raw material as a visceral fat accumulation inhibitor to prepare a raw material-containing feed. In this raw material-containing feed, salmon extract, bonito extract, and chicken extract were each contained at 32.5% by weight, and were administered separately from the above blended feed. Table 3 shows the content ratio (% by weight) of creatine and anserine contained in these test substances and the weight ratio thereof. Table 4 shows the weight percentages of anserine and creatine in the feed containing raw materials containing these test substances. Table 5 shows the average intake per kg body weight of anserine and creatine per day during the test period.

コントロール群には被験物質の代わりにカゼインを配合した飼料を投与した。肥満誘導群は、5週間の試験期間のうち最初から被験物質投与を行った。週に1回各個体の体重測定を行い、エンドポイント(5週目)に氷中で安楽死させたのち、肝臓を摘出した。摘出肝臓の凍結組織切片を実施例1と同様にして作製しオイルレッドO染色法により肝臓組織脂肪染色を行い、光学顕微鏡で画像を取得した。画像解析ソフトWinROOF(三谷商事株式会社)を用いて視野内の全細胞面積のうち染色部位面積の割合を定量した。   The control group received a feed containing casein instead of the test substance. In the obesity induction group, the test substance was administered from the beginning of the 5-week test period. Each individual was weighed once a week, euthanized on ice at the end point (5th week), and then the liver was removed. A frozen tissue section of the extracted liver was prepared in the same manner as in Example 1, and liver tissue fat was stained by an oil red O staining method, and an image was obtained with an optical microscope. Using the image analysis software WinROOF (Mitani Corporation), the proportion of the stained area out of the total cell area in the visual field was quantified.

結果を図5および図6に示す。肥満(誘導)コントロール群に対して、各エキス投与群では体重増加に有意な差は見られなかった一方で、肝臓脂肪蓄積が有意に低下した。   The results are shown in FIG. 5 and FIG. While no significant difference was seen in weight gain in each extract administration group compared to the obesity (induction) control group, liver fat accumulation was significantly reduced.

Claims (14)

アンセリンとクレアチンをともに有効成分として含有することを特徴とする飼育動物の内臓脂肪蓄積を抑制するための素材。   A material for suppressing visceral fat accumulation in domestic animals characterized by containing both anserine and creatine as active ingredients. 重量基準における配合割合でクレアチンを1としたとき、アンセリンを5.8以上57未満で含有する請求項1記載の素材。   The raw material according to claim 1, which contains anserine in an amount of 5.8 or more and less than 57 when the creatine content is 1 on a weight basis. 賦形剤または希釈剤を含み、製剤化されている請求項2に記載の素材。   The material according to claim 2, which contains an excipient or a diluent and is formulated. 請求項2または3のいずれか1項に記載の素材を含む飼育動物用の飼料。   The feed for domestic animals containing the raw material of any one of Claim 2 or 3. 前記飼育動物が養殖魚類である請求項4に記載の飼料。   The feed according to claim 4, wherein the domestic animal is a cultured fish. 前記飼育動物が畜産動物である請求項4に記載の飼料。   The feed according to claim 4, wherein the domestic animal is a livestock animal. 前記飼育動物がペット動物である請求項4に記載の飼料。   The feed according to claim 4, wherein the domestic animal is a pet animal. 請求項5から7に記載の飼料を、飼料中のクレアチンの摂取量として一日あたり7.7 mg/kg体重〜169 mg/kg体重で飼育動物に給餌することを特徴とする飼育動物の飼育方法。   Breeding of domestic animals characterized by feeding the domestic animal with the feed according to any one of claims 5 to 7 as creatine intake in the feed at a daily dose of 7.7 mg / kg body weight to 169 mg / kg body weight Method. 飼育動物用の飼料と、請求項1から4のいずれか1項に記載の素材または飼料とを請求項8を満たして、併用して給餌することを特徴とする飼育動物の飼育方法。   A method for raising domestic animals, comprising feeding for domestic animals and the raw material or feed according to any one of claims 1 to 4 satisfying claim 8 and feeding in combination. 飼育動物用の飼料と、請求項1から4のいずれか1項に記載の素材または飼料とを混合したものを、請求項8を満たして給餌することを特徴とする飼育動物の飼育方法。   A method for raising a domestic animal, comprising feeding a domestic animal feed and the raw material or feed according to any one of claims 1 to 4 while satisfying claim 8. 前記飼料と前記素材を別に用意して併用する請求項9または10に記載の飼育方法。   The breeding method according to claim 9 or 10, wherein the feed and the material are separately prepared and used together. 飼育動物が、養殖魚類、畜産動物またはペット動物である請求項8から11のいずれか1項に記載の飼育方法。   The breeding method according to any one of claims 8 to 11, wherein the breeding animal is a cultured fish, a livestock animal or a pet animal. 飼育動物用の飼料と、該飼料とは別に用意された請求項2または3のいずれか1項に記載の素材を有することを特徴とする飼育動物の飼育用のセット。   A feed set for domestic animals, comprising a feed for domestic animals and the material according to any one of claims 2 and 3 prepared separately from the feed. 飼育動物が、養殖魚類、畜産動物またはペット動物である請求項13に記載のセット。   14. The set according to claim 13, wherein the domestic animal is a cultured fish, livestock animal or pet animal.
JP2014026583A 2014-02-14 2014-02-14 Composition for suppressing visceral fat accumulation in farmed fish, livestock animals, pet animals, and animal feed using the composition for suppressing visceral fat accumulation Expired - Fee Related JP6017474B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2014026583A JP6017474B2 (en) 2014-02-14 2014-02-14 Composition for suppressing visceral fat accumulation in farmed fish, livestock animals, pet animals, and animal feed using the composition for suppressing visceral fat accumulation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2014026583A JP6017474B2 (en) 2014-02-14 2014-02-14 Composition for suppressing visceral fat accumulation in farmed fish, livestock animals, pet animals, and animal feed using the composition for suppressing visceral fat accumulation

Publications (2)

Publication Number Publication Date
JP2015151366A true JP2015151366A (en) 2015-08-24
JP6017474B2 JP6017474B2 (en) 2016-11-02

Family

ID=53893997

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014026583A Expired - Fee Related JP6017474B2 (en) 2014-02-14 2014-02-14 Composition for suppressing visceral fat accumulation in farmed fish, livestock animals, pet animals, and animal feed using the composition for suppressing visceral fat accumulation

Country Status (1)

Country Link
JP (1) JP6017474B2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017057175A (en) * 2015-09-18 2017-03-23 株式会社保健科学研究所 Muscle increasing agent
CN108308457A (en) * 2018-02-12 2018-07-24 集美大学 A kind of composite feed additive and the preparation method and application thereof improving jewfish liver mitochondrion function
JP7248772B1 (en) 2021-12-21 2023-03-29 マルハニチロ株式会社 Seriola farmed fish and method for raising Seriola farmed fish

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07250613A (en) * 1994-03-14 1995-10-03 Towa Chem Ind Co Ltd Production of dried and salted fish meat product
JPH09191860A (en) * 1996-01-18 1997-07-29 Ikari Super Market:Kk Production of packaged food for microwave cooking and white sauce for the food
JP2000198739A (en) * 1999-01-05 2000-07-18 Tokiwa Yakuhin Kogyo Kk Pharmaceutical composition for improving lipid metabolism or preventing or treating obesity containing chicken extract
JP2001122235A (en) * 1999-10-27 2001-05-08 Shisukomu:Kk Method for issuing display label for sales of perishable foods

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07250613A (en) * 1994-03-14 1995-10-03 Towa Chem Ind Co Ltd Production of dried and salted fish meat product
JPH09191860A (en) * 1996-01-18 1997-07-29 Ikari Super Market:Kk Production of packaged food for microwave cooking and white sauce for the food
JP2000198739A (en) * 1999-01-05 2000-07-18 Tokiwa Yakuhin Kogyo Kk Pharmaceutical composition for improving lipid metabolism or preventing or treating obesity containing chicken extract
JP2001122235A (en) * 1999-10-27 2001-05-08 Shisukomu:Kk Method for issuing display label for sales of perishable foods

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6016003469; 日本水産学会誌 Vol.74, No.6, 2008, p.1075-1081 *
JPN6016003473; 肥満研究 Vol.15, No.2, 2009, p.202-207 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017057175A (en) * 2015-09-18 2017-03-23 株式会社保健科学研究所 Muscle increasing agent
CN108308457A (en) * 2018-02-12 2018-07-24 集美大学 A kind of composite feed additive and the preparation method and application thereof improving jewfish liver mitochondrion function
JP7248772B1 (en) 2021-12-21 2023-03-29 マルハニチロ株式会社 Seriola farmed fish and method for raising Seriola farmed fish
JP2023091832A (en) * 2021-12-21 2023-07-03 マルハニチロ株式会社 Genus seriola cultured fish, and raising method of genus seriola cultured fish

Also Published As

Publication number Publication date
JP6017474B2 (en) 2016-11-02

Similar Documents

Publication Publication Date Title
Martínez-Alvarez et al. Protein hydrolysates from animal processing by-products as a source of bioactive molecules with interest in animal feeding: A review
AU2019264860B2 (en) Sugar cane extracts for use in animal feeds
DK2371226T3 (en) BILD SALT ADJUSTMENT TO ANIMALS TO IMPROVE THE FAT USE EFFECTIVENESS OF ANIMAL ORGANIZATIONS
Jalees et al. Effects of cottonseed meal on hematological, biochemical and behavioral alterations in male Japanese quail (Coturnix japonica).
JP2005151928A (en) Additive for feed
Abbas et al. Effect of supplementation of Nigella sativa seeds to the broiler chicks diet on the performance and carcass quality
JP6017474B2 (en) Composition for suppressing visceral fat accumulation in farmed fish, livestock animals, pet animals, and animal feed using the composition for suppressing visceral fat accumulation
JP2542655B2 (en) Mixed feed for animals
SI22407A (en) Application of coenzyme q10 for more effective breeding of animals and obtaining animal tissues with increased content of this coenzyme
JPH08185A (en) Improved edible egg and edible meat and their production
US20180014556A1 (en) Animal feed supplement composition
JP2011502516A (en) Drugs aimed at improving carcass performance in finishing pigs
JP5409989B2 (en) Food and drink for animals containing sesamin
WO2014025019A1 (en) Animal feed and stress reducer for industrial animals
CN105707468B (en) Phagostimulant for improving palatability of fish-meal-free giant freshwater prawn feed
Gjorgovska et al. Application of Rose Hip Fruits as Feed Supplement in Animal Nutrition
JP2006081530A (en) Oral administration composition for animal, and method for producing the same
JP2006304755A (en) Food for pet
JP3480047B2 (en) Rearing method with ginkgo biloba extract
JP2017109944A (en) In vivo fatty acid content increasing agent
JP2013179929A (en) Feed composition for fish or crustacea, and method for rearing the fish or crustaccea
JP2009247339A (en) Animal health maintaining agent, feed containing the same and rearing method
Nguyen et al. Effect of organic acid products on growth performance and intestine health of Tam Hoang chicken
Diogo et al. Use of essential oils in the diet of slow-growing broilers and their effects on performance
JP2009159942A (en) Livestock feed for stimulating growth of livestock

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20150501

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160209

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160408

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160726

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160902

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20160920

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20160928

R150 Certificate of patent or registration of utility model

Ref document number: 6017474

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees